Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

Recruiting now · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)

In brief

The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).

Key facts

Study ID
NCT05267821
Run by
Nationwide Children's Hospital
People needed
500
Starts
2022-06-14
Expected to finish
2028-08-31
Last updated by the study team
2026-03-13

Who can join

Age: 0 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.